Christopher Pierce
Analyst
Needham
Equibles does not estimate personal net worth.
About Christopher Pierce
Christopher Pierce is recorded as Analyst at Needham. The proxy statement of Prelude Therapeutics Inc reports total compensation of $3,930,865 for Christopher Pierce in fiscal 2020, including a base salary of $204,029.
Affiliation history
-
Needham
Analyst
Source not stated
Current -
Prelude Therapeutics Inc (PRLD)
Proxy statement
Start not stated–2021-09-30
Company network
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2020 | Prelude Therapeutics Inc (PRLD) | M.B.A. Executive Vice President andChief of Business Operations | $204,029 | $3,930,865 |
Recent activity
No call appearances or filed executive changes recorded yet.